27.04.2020 capsensixx AG  DE000A2G9M17

DGAP-News: capsensixx AG: capsensixx exceeds 2019 forecast with leap in earnings and starts successfully into 2020


 

DGAP-News: capsensixx AG / Key word(s): Annual Results/Miscellaneous
capsensixx AG: capsensixx exceeds 2019 forecast with leap in earnings and starts successfully into 2020

27.04.2020 / 09:32
The issuer is solely responsible for the content of this announcement.


capsensixx exceeds 2019 forecast with leap in earnings and starts successfully into 2020

- Focusing on core investments Axxion and Oaklet drives profit

- Net income for the year from continuing operations rises by 56% to EUR 7.4 million

- Earnings per share after minority interests turn from EUR -0.25 to EUR +0.70

- Continuation of the profitable, successful business development in Q1 / 2020

Frankfurt am Main, 27 April 2020 - capsensixx AG (ISIN DE000A2G9M17) has closed fiscal 2019 after the focusing on the profitable core investments Axxion S.A. and Oaklet GmbH with a leap in earnings and recorded a successful development in the first quarter 2020, too. The forecasts for the fiscal year were exceeded both for the earnings indicators and the Assets under Administration.

The 2019 EBITDA of the Group of EUR 10.1 million in accordance with audited figures according to IFRS accounting was very significantly above the prior year value of EUR 7.9 million. The prior year data were adjusted within the framework of the preparation of the current financial statements because of subsequently established impairments in the former consolidated company coraixx, which was deconsolidated at the end of 2019. Axxion (share in the EBITDA of around 80%) and Oaklet (share of around 20%) made equal contributions to the successful development of the result. The consolidated net income for the year from continuing operations according to IFRS leaped by 56% from EUR 4.7 million to EUR 7.4 million and testifies to the high earning capacity of the two core investments. The net income for the year including the discontinued operations amounted in 2019 to a total of EUR 5.1 million after EUR 2.3 million during the previous year and after minority interests to EUR 2.4 million after EUR -0.6 million during the previous year. As a result, the earnings per share turned to EUR +0.70 after EUR -0.25 in the prior year.

The Assets under Administration rose through the end of the year 2019 to about EUR 9 billion and were hence EUR 500 million above the year-end value 2018. The net commission income amounted on a Group level to EUR 23.3 million during the past fiscal year and was slightly above the prior year value of EUR 23.0 million. As at 31 December 2019 capsensixx had cash in banks in the amount of EUR 7.4 million as well as financial instruments and other financial assets of EUR 5.5 million; the equity ratio amounted to 44 percent at the end of the year. Against this backdrop, capsensixx sees itself as very solidly positioned.

The successful development of capsensixx has also continued during the first quarter of the current fiscal year. Despite the turbulence on the financial markets caused by the COVID-19 virus, the first quarter 2020 ended profitably and with a net income after minority interests above the comparative prior year period. The concrete impact of COVID-19 on the economic and business development in the further course of the year cannot yet be reliably forecasted for the moment. At present, capsensixx anticipates a positive result for fiscal 2020.

Given the restrictions due to COVID-19, capsensixx will hold its ordinary general meeting for the past fiscal year originally scheduled to take place at the end of June 2020 probably in autumn 2020.

The full financial statements are available from today under www.capsensixx.de for downloading.

About capsensixx
capsensixx manages, structures, and executes financial products in various asset classes and product workflows in the financial sector for its customers (Financial Administration as a Service). The business model, which focuses on funds and alternative assets, is characterized by a high proportion of recurring income and profitable growth. The subsidiaries Axxion (capital management) and Oaklet (specialist for securitization and other financial services) have a very strong position on the German-speaking market in these two areas.
You can find more information at www.capsensixx.de

Contact:

capsensixx AG
Bettinastraße 57-59
D-60325 Frankfurt am Main
Tel. 069 / 7680 585 0
Fax. 069 / 7680 585 20
Email: [email protected]

Media Relations
edicto GmbH
Axel Mühlhaus/ Dr. Sönke Knop
Tel. +49(0) 69/905505-52
Email: [email protected]



27.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: capsensixx AG
Bettinastraße 57-59
60325 Frankfurt
Germany
E-mail: [email protected]
Internet: www.capsensixx.de
ISIN: DE000A2G9M17
WKN: A2G9M1
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1030083

 
End of News DGAP News Service

1030083  27.04.2020 

fncls.ssp?fn=show_t_gif&application_id=1030083&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 69,46 65,54 116,20 116,66 112,09 110,31 0,00
EBITDA1,2 7,45 6,56 8,17 7,86 10,12 8,13 0,00
EBITDA-Marge3 10,73 10,01 7,03 6,74 9,03 7,37 0,00
EBIT1,4 6,88 5,81 7,19 4,46 7,25 6,17 0,00
EBIT-Marge5 9,90 8,86 6,19 3,82 6,47 5,59 0,00
Jahresüberschuss1 4,83 4,07 4,98 2,34 5,08 4,65 0,00
Netto-Marge6 6,95 6,21 4,29 2,01 4,53 4,22 0,00
Cashflow1,7 5,23 3,14 5,95 5,81 0,74 6,08 0,00
Ergebnis je Aktie8 0,71 0,60 0,74 -0,25 0,70 0,66 0,71
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Capsensixx
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2G9M1 15,900 Halten 54,54
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
20,38 15,00 1,36 28,75
KBV KCV KUV EV/EBITDA
4,49 8,97 0,49 5,63
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,00 0,00 0,00 23.06.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
28.05.2021 30.08.2021 29.11.2021 27.04.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
1,76% 6,90% 24,22% 15,22%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu capsensixx AG  ISIN: DE000A2G9M17 können Sie bei DGAP abrufen

Finanzdienstleistungen , A2G9M1 , CPX , XETR:CPX